J Medrano Selected Research

Venous Thromboembolism

5/2001

Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Medrano Research Topics

Disease

2	Carcinoma (Carcinomatosis) 04/2005 - 07/2000
2	Neoplasms (Cancer) 07/2000 - 01/2000
1	Lymphatic Metastasis 03/2020
1	Rheumatoid Arthritis 07/2015
1	Infections 07/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2011
1	Fibrosis (Cirrhosis) 08/2011
1	Hepatitis C 05/2011
1	Alcoholism (Alcohol Abuse) 01/2011
1	Insulin Resistance 01/2011
1	Chronic Hepatitis C 01/2011
1	Abscess 07/2009
1	Hemorrhage 07/2009
1	Abdominal Abscess 07/2009
1	Hemoptysis 02/2006
1	Lacrimal Duct Obstruction 06/2003
1	Thrombosis (Thrombus) 05/2001
1	Venous Thromboembolism 05/2001
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2001
1	Thromboembolism 02/2001
1	Lacrimal Apparatus Diseases (Epiphora) 01/2001
1	Wounds and Injuries (Trauma) 03/2000
1	Pilonidal Sinus (Pilonidal Cyst) 03/2000
1	Pain (Aches) 03/2000
1	Breast Neoplasms (Breast Cancer) 01/2000
1	Male Breast Neoplasms (Male Breast Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 04/2005 - 07/2000
1	folfirinoxIBA 03/2020
1	RNA (Ribonucleic Acid)IBA 08/2011
1	Ribavirin (Virazole)FDA LinkGeneric 08/2011
1	InterferonsIBA 08/2011
1	Didanosine (Videx)FDA LinkGeneric 01/2011
1	CholesterolIBA 01/2011
1	NucleosidesIBA 01/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	Stavudine (Zerit)FDA LinkGeneric 01/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2009
1	multidrug resistance-associated protein 1IBA 04/2005
1	Multidrug Resistance-Associated ProteinsIBA 04/2005
1	Monoclonal AntibodiesIBA 04/2005
1	Messenger RNA (mRNA)IBA 04/2005
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 06/2003
1	Polyurethanes (Polyurethane)IBA 06/2003
1	Heparin (Liquaemin)FDA LinkGeneric 05/2001
1	Nadroparin (Nadroparin Calcium)IBA 05/2001
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2001
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2001
1	AntibodiesIBA 07/2000
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2000
1	Colloids (Colloid)IBA 03/2000
1	Apolipoproteins D (Apo D)IBA 01/2000
1	Estrogens (Estrogen)FDA Link 01/2000
1	AndrogensIBA 01/2000
1	Estrogen ReceptorsIBA 01/2000
1	Pepsinogen CIBA 01/2000

Therapy/Procedure

2	Therapeutics 08/2011 - 05/2011
2	Stents 06/2003 - 01/2001
1	Pancreatectomy 03/2020
1	Induction Chemotherapy 03/2020
1	Biological Therapy 07/2015
1	Length of Stay 07/2009
1	Minimally Invasive Surgical Procedures 02/2006
1	Hydrocolloid Bandages (Duoderm) 03/2000